- Home
- TLSI vs BKTI Comparison
TLSI vs BKTI Comparison
Compare TLSI & BKTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSI | BKTI |
|---|---|---|
| Founded | 2010 | 1997 |
| Country | United States | United States |
| Employees | 110 | N/A |
| Industry | Medical Specialities | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.1M | 277.9M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | TLSI | BKTI |
|---|---|---|
| Price | $4.00 | $73.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $74.00 |
| AVG Volume (30 Days) | ★ 197.9K | 46.4K |
| Earning Date | 03-05-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 52.89 |
| EPS | N/A | ★ 3.44 |
| Revenue | N/A | ★ $74,094,000.00 |
| Revenue This Year | $36.47 | $10.83 |
| Revenue Next Year | $39.31 | N/A |
| P/E Ratio | ★ N/A | $21.30 |
| Revenue Growth | N/A | ★ 45.42 |
| 52 Week Low | $3.42 | $35.76 |
| 52 Week High | $7.95 | $89.50 |
Technical Indicators
Market Signals| Indicator | TLSI | BKTI |
|---|---|---|
| Relative Strength Index (RSI) | 41.17 | 39.09 |
| Support Level | $3.79 | $73.60 |
| Resistance Level | $5.33 | $76.69 |
| Average True Range (ATR) | 0.24 | 4.42 |
| MACD | 0.02 | -0.75 |
| Stochastic Oscillator | 48.05 | 36.24 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About BKTI BK Technologies Corporation
BK Technologies Corp is a holding company that, through BK Technologies, Inc., its operating subsidiary, provides public safety-grade communications products and services designed to make first responders safer and more efficient. All operating activities described herein are undertaken by its operating subsidiary. The Company has one reportable segment - Land Mobile Radio (LMR) Products and Solutions. The LMR segment provides radio devices that are hand-held (portable) or installed in vehicles (mobile) and operate on private radio systems that are P25 compliant. The Company derives revenue in North America and manages the business activities on a consolidated basis.